Pancreatic transplantation: Beta cell replacement

Current Treatment Options in Gastroenterology

Volumn 7, Issue 5, 2004, Pages 329-341

  Bigam, David L ^a   Shapiro, A M James ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; DACLIZUMAB; DIPHENHYDRAMINE; GANCICLOVIR; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; INSULIN; MACROLIDE; METHYLPREDNISOLONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NARCOTIC AGENT; NYSTATIN; OKT 3; ORAL ANTIDIABETIC AGENT; PARACETAMOL; PREDNISONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ANEMIA; AUTOTRANSPLANTATION; AVASCULAR NECROSIS; BACTERIAL INFECTION; BONE MARROW SUPPRESSION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CELL TRANSPLANTATION; CHRONIC PANCREATITIS; CORTICOSTEROID INDUCED OSTEOPOROSIS; COST EFFECTIVENESS ANALYSIS; CUSHINGOID SYNDROME; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIARRHEA; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; EVIDENCE BASED MEDICINE; GASTROINTESTINAL DISEASE; GINGIVA HYPERPLASIA; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GRAFT REJECTION; HIRSUTISM; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LEUKOPENIA; LUNG EDEMA; LYMPHOPROLIFERATIVE DISEASE; METABOLIC DISORDER; MORBIDITY; MOUTH ULCER; NEPHROTOXICITY; NEUROTOXICITY; OVARY CYST; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PANCYTOPENIA; PEPTIC ULCER; PERIOPERATIVE PERIOD; PERIPHERAL EDEMA; PNEUMOCYSTOSIS; PROGNOSIS; QUALITY OF LIFE; REVIEW; SURVIVAL TIME; THROMBOCYTOPENIA; THRUSH; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VIRUS INFECTION;

EID: 8344232731     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-004-0046-9     Document Type: Review

References (35)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993, 329: 77-986.
2. Stratta RJ, Lo A, Shokouh-Amiri MH, et al.: Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression. Transpl Int, 16:154-160.
3. Kaufman DB, Burke GW, Bruce DS, et al.: Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation. Am J Transplant 2003, 3:855-864.
4. Tan M, Cantarovich M, Mangel R, et al.: Reduced dose Thymoglobulin, tacrolimus, and mofetil mycophenolate results in excellent solitary pancreas transplantation outcomes. Clin Transplant 2002, 16:414-418.
5. Kaufman DB, Leventhal JR, Koffrom AJ, et al.: A prospective study of rapid corticosteroid elimination in simultaneous pancreas-kidney transplantation: comparison of two maintenance immunosuppression protocols: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation 2002, 73:169-177.
6. Freise CE, Kang S-M, Feng S, et al.: Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation. Arch Surg 2003, 138:1121-1125; discussion 1125-1126.
7. Akalin E, Sehgal V, Ames S, et al.: Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis. Am J Transplant 2003, 3: 31-735.
8. Trofe J, Gaber LW, Stratta RJ, et al.: Polyomavirus in kidney and kidney-pancreas transplant recipients. Transpl Infect Dis 2003, 5:21-28.
9. Drachenberg CB, Rlassen DK, Weir MR, et al.: Islet cell damage associated with tacrolimus and cydosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation 1999, 68:396-402.
10. Reddy KS, Davies D, Ormond D, et al.: Impact of acute rejection episodes on long-term graft survival following simultaneous kidney-pancreas transplantation. Am J Transplant 2003, 3:439-444.
11. Humar A, Khwaja K, Ramcharan T, et al.: Chronic rejection: the next major challenge for pancreas transplant recipients Transplantation 2003, 76:918-923.
12. Ryan EA, Shandro T, Green K, et al.: Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004, 53 955-962.
13. Lakey JR, Burridge PW, Shapiro AM: Technical aspects of islet preparation and transplantation. Transpl Int 2003, 16 613-632.
14. Lakey JR, Kneteman NM, Rajotte RV, et al.: Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation 2002, 73 1106-1110.
15. Owen RJ, Ryan EA, O'Kelly K, et al.: Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology 2003, 229:165-170.
16. Shapiro AM, Lakey JR, Ryan EA, et al.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunoppressive regimen. N Engl J Med 2000, 343:230-238.
17. Ryan EA, Lakey JRT, Paty BW, et al.: Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002, 51:2148-57.
18. Ryan EA, Lakey JRT, Rajotte RV, et al.: Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001, 50:710-19.
19. Bigam DL, Hemming AW, Sanabria JR, et al.: Innominate artery interposition graft simplifies the portal venous drainage method of pancreas transplantation. Transplantation 1999, 68:314-315.
20. Venstrom JM, McBride MA, Rother KI, et al.: Survival after pancreas transplantation in patients with diabetes and preserved kidney function. Jama 2003, 290:2817-2823.
21. Bartlett ST, Schweitzer EJ, Johnson LB, et al.: Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy. Ann Surg 1996, 224:440-9; discussion 449-452.
22. Cattral MS, Bigam DL, Hemming AW, et al.: Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: clinical outcome of 40 consecutive transplant recipients. Ann Surg 2000, 232:688-695.
23. Sutherland DE, Gruessner RWG, Dunn DL, et al.: Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001, 233:463-501.
24. Sollinger HW, Odorico JS, Knechtle SJ, et al.: Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg 1998, 228:284-296.
25. Lin K, Cooper S, Davies CL: Pre-transplant cardiac testing for kidney-pancreas transplant candidates and association with cardiac outcomes. Clin Transplant 2001, 15:269-275.
26. Humar A, Kandaswamy R, Grnager D, et al.: Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg 2000, 231:269-275.
27. Philosophe B, Farney AC, Schweitzer EJ, et al.: Superiority of portal venous drainage over systemic venous drainage in pancreas transplantation: a retrospective study. Ann Surg 2001, 234:689-696.
28. Gaber AO, Shokouh-Amiri MH, Hathaway DK, et al.: Results of pancreas transplantation with portal venous and enteric drainage. Ann Surg 1995, 221:613-622; discussion 622-624.
29. Stratta RJ, Shokouh-Amiri MH, Egidi MF, et al.: Longterm experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression. Clin Transplant 2003, 17 Suppl 9:69-77.
30. Carpentier A, Patterson B, Uffelman KD, et al.: The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism. Diabetes 2001, 50:1402-1413.
31. Hariharan S, Pirsch JD, Lu CY, et al.: Pancreas after kidney transplantation. J Am Soc Nephrol 2002, 13: 109-1118.
32. Humar A, Ramcharan T, Kandaswarmy R, et al.: Pancreas after kidney transplants. Am J Surg 2001, 182: 55-161.
33. Robertson RP, Dennison AR, Johnso PRV, et al.: Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation 2002, 73:736-741.
34. Clayton HA, Davies JE, Pollard CA, et al.: Pancreatectomy with islet autotransplantation for the treatment of severe chronic pancreatitis: the first 40 patients at the Leicester general hospital. Transplantation 2003, 76:92-98.
35. Gruessner RW, Sutherland DER, Dunn DL, et al.: Transplant options for patients undergoing total pancreatectomy for chronic pancreatitis. J Am Coll Surg 2004, 198:559-567; discussion 568-569.